diaendoСахарный диабетDiabetes mellitus2072-03512072-0378Endocrinology research centre10.14341/DM13027diaendo-13048Research ArticleНовостиNewsЭкзокринная недостаточность поджелудочной железы при сахарном диабете 1 и 2 типаPancreatic exocrine insufficiency in diabetes mellitushttps://orcid.org/0000-0002-5057-127XШестаковаМ. В.ShestakovaM. V.

Шестакова Марина Владимировна, д.м.н., профессор, академик РАН

Scopus Author ID: 7004195530; eLibrary SPIN: 7584-7015

Москва

Marina V. Shestakova, MD, PhD, Professor, Academician of the Russian Academy of Sciences

Scopus Author ID: 7004195530; eLibrary SPIN: 7584-7015

Moscow

Shestakova.Marina@endocrincentr.ruhttps://orcid.org/0000-0001-6114-564XМаевИ. В.MaevI. V.

Маев Игорь Вениаминович, д.м.н., профессор, академик РАН

Scopus Author ID: 7006155179; ResearcherID: N-9320-2014; eLibrary SPIN: 1994-0933

Москва

Igor V. Maev, MD, PhD, Academician of the Russian Academy of Sciences

Scopus Author ID: 7006155179; ResearcherID: N-9320-2014; eLibrary SPIN: 1994-0933

Moscow

igormaev@rambler.ruhttps://orcid.org/0000-0002-7936-7619АметовА. С.AmetovA. S.

Аметов Александр Сергеевич, д.м.н., профессор

eLibrary SPIN: 9511-1413

Москва

Alexander S. Ametov, MD, PhD, Professor

eLibrary SPIN: 9511-1413

Moscow

alexander.ametov@gmail.comhttps://orcid.org/0000-0002-9944-2997АнциферовМ. Б.AntsiferovM. B.

Анциферов Михаил Борисович, д.м.н., профессор

eLibrary SPIN: 1035-4773

Москва

Mikhail B. Antsiferov, MD, PhD, Professor

eLibrary SPIN: 1035-4773

Moscow

antsiferov@rambler.ruhttps://orcid.org/0000-0003-2815-3992БординД. С.BordinD. S.

Бордин Дмитрий Станиславович, д.м.н., профессор

Scopus Author ID: 57559491100; ResearcherID: M-4708-2017; eLibrary SPIN: 6331-6323

Москва; Тверь

Dmitry S. Bordin, MD, PhD, Professor

Scopus Author ID: 57559491100; ResearcherID: M-4708-2017; eLibrary SPIN: 6331-6323

Moscow; Tver

dbordin@mail.ruhttps://orcid.org/0000-0001-6581-4521ГалстянГ. Р.GalstyanG. R.

Галстян Гагик Радикович, д.м.н., профессор

Scopus Author ID: 6701438348; eLibrary SPIN: 9815-7509

Москва

Gagik R. Galstyan, MD, PhD, Professor

Scopus Author ID: 6701438348; eLibrary SPIN: 9815-7509

Moscow

galstyangagik964@gmail.comhttps://orcid.org/0000-0002-0327-4619ДзгоеваФ. Х.DzgoevaF. K.

Дзгоева Фатима Хаджимуратовна, к.м.н.

eLibrary SPIN: 9315-0722

117036, Москва, ул. Дм. Ульянова, д. 11

Fatima K. Dzgoeva, MD, PhD

11 Dm. Ulyanova street, 117036 Moscow

eLibrary SPIN: 9315-0722

Moscow

fatima.dzgoeva@gmail.comhttps://orcid.org/0000-0001-7760-2091КучерявыйЮ. А.KucheryavyyY. A.

Кучерявый Юрий Александрович, к.м.н., доцент

eLibrary SPIN: 4503-8807

Красногорск

Yury A. Kucheryavyy, MD, PhD, Associate Professor

eLibrary SPIN: 4503-8807

Krasnogorsk

proped@mail.ruhttps://orcid.org/0000-0003-1316-5245МкртумянА. М.MkrtumyanA. M.

Мкртумян Ашот Мусаелович, д.м.н., профессор

Author ID: 513441; eLibrary SPIN: 1980-8700

Москва

Ashot M. Mkrtumyan, MD, PhD, Professor

Author ID: 513441; eLibrary SPIN: 1980-8700

Moscow

vagrashot@mail.ruhttps://orcid.org/0000-0001-5656-2596НиконоваТ. В.NikonovaT. V.

Никонова Татьяна Васильевна, д.м.н.

Scopus Author ID: 55553886600; eLibrary SPIN: 8863-0201

Москва

Tatiana V. Nikonova, MD, PhD

Scopus Author ID: 55553886600; eLibrary SPIN: 8863-0201

Moscow

tatiana_nikonova@mail.ruhttps://orcid.org/0000-0003-1949-914XПашковаЕ. Ю.PashkovaE. Y.

Пашкова Евгения Юрьевна, к.м.н.

Scopus Author ID: 57226576419; e-Library SPIN: 4948-8315

Москва

Evgeniya Y. Pashkova, MD, PhD

Scopus Author ID: 57226576419; e-Library SPIN: 4948-8315

Moscow

parlodel@mail.ruНациональный исследовательский центр эндокринологииРоссияEndocrinology Research CentreRussian FederationМосковский государственный медико-стоматологический университет им. А.И. ЕвдокимоваРоссияA.I. Yevdokimov Moscow State University of Medicine and DentistryRussian FederationРоссийская медицинская академия непрерывного профессионального образованияРоссияRussian Medical Academy of Continuous Professional EducationRussian FederationРоссийская медицинская академия непрерывного профессионального образования; Эндокринологический диспансерРоссияEndocrinological Dispensary of the Moscow City Health DepartmentRussian FederationМосковский государственный медико-стоматологический университет им. А.И. Евдокимова; Московский клинический научно-практический центр им. А.С. Логинова; Тверской государственный медицинский университетРоссияA.I. Yevdokimov Moscow State University of Medicine and Dentistry; A.S. Loginov Moscow Clinical Scientific Centre; Tver State Medical UniversityRussian FederationИльинская больницаРоссияIlyinsky HospitalRussian FederationМосковский государственный медико-стоматологический университет им. А.И. Евдокимова; Московский клинический научно-практический центр им. А.С. ЛогиноваРоссияA.I. Yevdokimov Moscow State University of Medicine and Dentistry; A.S. Loginov Moscow Clinical Scientific CentreRussian FederationРоссийская медицинская академия непрерывного профессионального образования; Городская клиническая больница им. С.П. БоткинаРоссияRussian Medical Academy of Continuous Professional Education; Botkin HospitalRussian Federation20232105202326213048Copyright © Шестакова М.В., Маев И.В., Аметов А.С., Анциферов М.Б., Бордин Д.С., Галстян Г.Р., Дзгоева Ф.Х., Кучерявый Ю.А., Мкртумян А.М., Никонова Т.В., Пашкова Е.Ю., 20232023Шестакова М.В., Маев И.В., Аметов А.С., Анциферов М.Б., Бордин Д.С., Галстян Г.Р., Дзгоева Ф.Х., Кучерявый Ю.А., Мкртумян А.М., Никонова Т.В., Пашкова Е.Ю.Shestakova M.V., Maev I.V., Ametov A.S., Antsiferov M.B., Bordin D.S., Galstyan G.R., Dzgoeva F.K., Kucheryavyy Y.A., Mkrtumyan A.M., Nikonova T.V., Pashkova E.Y.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.dia-endojournals.ru/jour/article/view/13048

Сахарный диабет — заболевание как эндо-, так и экзокринной части поджелудочной железы. Экзокринная недостаточность поджелудочной железы при сахарном диабете может встречаться у каждого 2–3-го пациента и влиять не только на качество, но и на продолжительность жизни. При этом диагностике и лечению панкреатической недостаточности не уделяется должного внимания. Эндокринолог, как основной специалист, ведущий пациентов с сахарным диабетом наравне с гастроэнтерологом и терапевтом, может предположить наличие экзокринной недостаточности поджелудочной железы у пациента и самостоятельно принимать решение о ее коррекции с помощью заместительной ферментной терапии адекватными дозами.

Diabetes is disease of both the endo- and exocrine parts of the pancreas. Pancreatic exocrine insufficiency (PEI) can occur in every 2–3 patients with diabetes and affect not only the quality, but also life expectancy. At the same time, the diagnosis and treatment of PEI is not getting enough attention. The endocrinologist, as the main specialist leading patients with diabetes, can diagnose and treat patients with pancreatic exocrine insufficiency and diabetes using adequate doses of pancreatic enzyme replacement therapy (PERT).

ферментная недостаточностьэкзокринная недостаточность поджелудочной железыЭНПЖсахарный диабетпанкреатинзаместительная ферментная терапияминимикросферыpancreatic exocrine insufficiencyPEIpancreatic enzyme replacement therapyPERTdiabetespancreatinminimicrospheresРабота выполнена по инициативе авторов без привлечения финансирования.ReferencesLindkvist B. Diagnosis and treatment of pancreatic exocrine insufficiency. World J Gastroenterol. 2013;19(42):7258. doi: https://doi.org/10.3748/wjg.v19.i42.7258Lindkvist B. Diagnosis and treatment of pancreatic exocrine insufficiency. World J Gastroenterol. 2013;19(42):7258. doi: https://doi.org/10.3748/wjg.v19.i42.7258Pezzilli R. Exocrine pancreatic insufficiency in adults: A shared position statement of the Italian association for the study of the pancreas. World J Gastroenterol. 2013;19(44):7930. doi: https://doi.org/10.3748/wjg.v19.i44.7930Pezzilli R. Exocrine pancreatic insufficiency in adults: A shared position statement of the Italian association for the study of the pancreas. World J Gastroenterol. 2013;19(44):7930. doi: https://doi.org/10.3748/wjg.v19.i44.7930Lindkvist B, Domínguez-Muñoz JE, Luaces-Regueira M, et al. Serum nutritional markers for prediction of pancreatic exocrine insufficiency in chronic pancreatitis. Pancreatology. 2012;12(4):305-310. doi: https://doi.org/10.1016/j.pan.2012.04.006Lindkvist B, Domínguez-Muñoz JE, Luaces-Regueira M, et al. Serum nutritional markers for prediction of pancreatic exocrine insufficiency in chronic pancreatitis. Pancreatology. 2012;12(4):305-310. doi: https://doi.org/10.1016/j.pan.2012.04.006Altay M. Which factors determine exocrine pancreatic dysfunction in diabetes mellitus? World J Gastroenterol. 2019;25(22):2699-2705. doi: https://doi.org/10.3748/wjg.v25.i22.2699Altay M. Which factors determine exocrine pancreatic dysfunction in diabetes mellitus? World J Gastroenterol. 2019;25(22):2699-2705. doi: https://doi.org/10.3748/wjg.v25.i22.2699Ahmed A, Deep A, Kothari DJ, Sheth SG. Bone disease in chronic pancreatitis. World J Clin Cases. 2020;8(9):1574-1579. doi: https://doi.org/10.12998/wjcc.v8.i9.1574Ahmed A, Deep A, Kothari DJ, Sheth SG. Bone disease in chronic pancreatitis. World J Clin Cases. 2020;8(9):1574-1579. doi: https://doi.org/10.12998/wjcc.v8.i9.1574Barkin JA, Barkin JS. Chronic Pancreatitis and Bone Disease. Journal of Clinical Densitometry. 2020;23(2):237-243. doi: https://doi.org/10.1016/j.jocd.2019.08.004Barkin JA, Barkin JS. Chronic Pancreatitis and Bone Disease. Journal of Clinical Densitometry. 2020;23(2):237-243. doi: https://doi.org/10.1016/j.jocd.2019.08.004Tignor AS, Wu BU, Whitlock TL, et al. High Prevalence of Low-Trauma Fracture in Chronic Pancreatitis. American Journal of Gastroenterology. 2010;105(12):2680-2686. doi: https://doi.org/10.1038/ajg.2010.325Tignor AS, Wu BU, Whitlock TL, et al. High Prevalence of Low-Trauma Fracture in Chronic Pancreatitis. American Journal of Gastroenterology. 2010;105(12):2680-2686. doi: https://doi.org/10.1038/ajg.2010.325Duggan SN, Smyth ND, Murphy A, et al. High Prevalence of Osteoporosis in Patients With Chronic Pancreatitis: A Systematic Review and Meta-analysis. Clinical Gastroenterology and Hepatology. 2014;12(2):219-228. doi: https://doi.org/10.1016/j.cgh.2013.06.016Duggan SN, Smyth ND, Murphy A, et al. High Prevalence of Osteoporosis in Patients With Chronic Pancreatitis: A Systematic Review and Meta-analysis. Clinical Gastroenterology and Hepatology. 2014;12(2):219-228. doi: https://doi.org/10.1016/j.cgh.2013.06.016Guéant J-L, Guéant-Rodriguez R-M, Alpers DH. Vitamin B12 absorption and malabsorption. Vitam Horm. 2022;119:241-274. doi: https://doi.org/10.1016/bs.vh.2022.01.016Guéant J-L, Guéant-Rodriguez R-M, Alpers DH. Vitamin B12 absorption and malabsorption. Vitam Horm. 2022;119:241-274. doi: https://doi.org/10.1016/bs.vh.2022.01.016European Pancreatic Club (EPC), European Digestive Surgery (EDS), European Society for Primary Care Gastroenterology (ESCPG), European Society for Paediatric Gastroenterology H and N (ESPGHAN), European Society for Clinical Nutrition and Metabolism (ESPEN), European Society of Digestive Oncology (ESDO), European Society of Primary Care Gastroenterology (ESPCG). European Guideline on the Diagnosis and Therapy of Pancreatic Exocrine Insufficiency (PEI). 2023. Доступно по: https://europeanpancreaticclub.org/about-us/diagnosis-and-treatment-Guidelines/ Ссылка активна на 09.05.2023European Pancreatic Club (EPC), European Digestive Surgery (EDS), European Society for Primary Care Gastroenterology (ESCPG), European Society for Paediatric Gastroenterology H and N (ESPGHAN), European Society for Clinical Nutrition and Metabolism (ESPEN), European Society of Digestive Oncology (ESDO), European Society of Primary Care Gastroenterology (ESPCG). European Guideline on the Diagnosis and Therapy of Pancreatic Exocrine Insufficiency (PEI). 2023. Доступно по: https://europeanpancreaticclub.org/about-us/diagnosis-and-treatment-Guidelines/ Ссылка активна на 09.05.2023Capurso G, Traini M, Piciucchi M, et al. Exocrine pancreatic insufficiency: prevalence, diagnosis, and management. Clin Exp Gastroenterol. 2019;12:129-139. doi: https://doi.org/10.2147/CEG.S168266Capurso G, Traini M, Piciucchi M, et al. Exocrine pancreatic insufficiency: prevalence, diagnosis, and management. Clin Exp Gastroenterol. 2019;12:129-139. doi: https://doi.org/10.2147/CEG.S168266Hart PA, Conwell DL. Diagnosis of Exocrine Pancreatic Insufficiency. Curr Treat Options Gastroenterol. 2015;13(3):347-353. doi: https://doi.org/10.1007/s11938-015-0057-8Hart PA, Conwell DL. Diagnosis of Exocrine Pancreatic Insufficiency. Curr Treat Options Gastroenterol. 2015;13(3):347-353. doi: https://doi.org/10.1007/s11938-015-0057-8Singh VK, Haupt ME, Geller DE, et al. Less common etiologies of exocrine pancreatic insufficiency. World J Gastroenterol. 2017;23(39):7059-7076. doi: https://doi.org/10.3748/wjg.v23.i39.7059Singh VK, Haupt ME, Geller DE, et al. Less common etiologies of exocrine pancreatic insufficiency. World J Gastroenterol. 2017;23(39):7059-7076. doi: https://doi.org/10.3748/wjg.v23.i39.7059Smith RC, Smith SF, Wilson J, et al. Summary and recommendations from the Australasian guidelines for the management of pancreatic exocrine insufficiency. Pancreatology. 2016;16(2):164-180. doi: https://doi.org/10.1016/j.pan.2015.12.006Smith RC, Smith SF, Wilson J, et al. Summary and recommendations from the Australasian guidelines for the management of pancreatic exocrine insufficiency. Pancreatology. 2016;16(2):164-180. doi: https://doi.org/10.1016/j.pan.2015.12.006Diéguez-Castillo C, Jiménez-Luna C, Prados J, et al. State of the Art in Exocrine Pancreatic Insufficiency. Medicina (B Aires). 2020;56(10):523. doi: https://doi.org/10.3390/medicina56100523Diéguez-Castillo C, Jiménez-Luna C, Prados J, et al. State of the Art in Exocrine Pancreatic Insufficiency. Medicina (B Aires). 2020;56(10):523. doi: https://doi.org/10.3390/medicina56100523Dominguez-Muñoz JE. Diagnosis and treatment of pancreatic exocrine insufficiency. Curr Opin Gastroenterol. 2018;34(5):349-354. doi: https://doi.org/10.1097/MOG.0000000000000459Dominguez-Muñoz JE. Diagnosis and treatment of pancreatic exocrine insufficiency. Curr Opin Gastroenterol. 2018;34(5):349-354. doi: https://doi.org/10.1097/MOG.0000000000000459Löhr JM, Dominguez‐Munoz E, Rosendahl J, et al. United European Gastroenterology evidence‐based guidelines for the diagnosis and therapy of chronic pancreatitis (HaPanEU). United European Gastroenterol J. 2017;5(2):153-199. doi: https://doi.org/10.1177/2050640616684695Löhr JM, Dominguez‐Munoz E, Rosendahl J, et al. United European Gastroenterology evidence‐based guidelines for the diagnosis and therapy of chronic pancreatitis (HaPanEU). United European Gastroenterol J. 2017;5(2):153-199. doi: https://doi.org/10.1177/2050640616684695Кучерявый ЮА., Бордин ДС. Обзор клинических рекомендаций по диагностике и лечению экзокринной панкреатической недостаточности // Экспериментальная и клиническая гастроэнтерология. — 2021 — №11. — С. 5-14. doi: https://doi.org/10.31146/1682-8658-ecg-195-11-5-14Kucheryavyy YuA, Bordin DS. A brief review of clinical guidelines for the diagnosis and treatment of exocrine pancreatic insufficiency. Experimental and Clinical Gastroenterology. 2021;(11):5-14. (In Russ.). doi: https://doi.org/10.31146/1682-8658-ecg-195-11-5-14Бордин ДС, Дубцова ЕА, Винокурова ЛВ, и др. Функциональная недостаточность поджелудочной железы после хирургического лечения в свете последних международных рекомендаций // Альманах клинической медицины. — 2017. — Т. 45. — №5. — С. 358-365. doi: https://doi.org/10.18786/2072-0505-2017-45-5-358-365Bordin DS, Dubtsova EA, Vinokurova LV, et al. Functional pancreatic insufficiency after surgical treatment in the light of the latest international recommendations. Alm Clin Med. 2017;45(5):358-365. (In Russ.). doi: https://doi.org/10.18786/2072-0505-2017-45-5-358-365Domínguez-Muñoz JE, D. Hardt P, Lerch MM, Löhr MJ. Potential for Screening for Pancreatic Exocrine Insufficiency Using the Fecal Elastase-1 Test. Dig Dis Sci. 2017;62(5):1119-1130. doi: https://doi.org/10.1007/s10620-017-4524-zDomínguez-Muñoz JE, D. Hardt P, Lerch MM, Löhr MJ. Potential for Screening for Pancreatic Exocrine Insufficiency Using the Fecal Elastase-1 Test. Dig Dis Sci. 2017;62(5):1119-1130. doi: https://doi.org/10.1007/s10620-017-4524-zLankisch PG. Secretion and absorption (methods and functions). Best Pract Res Clin Gastroenterol. 2009;23(3):325-335. doi: https://doi.org/10.1016/j.bpg.2009.03.001Lankisch PG. Secretion and absorption (methods and functions). Best Pract Res Clin Gastroenterol. 2009;23(3):325-335. doi: https://doi.org/10.1016/j.bpg.2009.03.001Radlinger B, Ramoser G, Kaser S. Exocrine Pancreatic Insufficiency in Type 1 and Type 2 Diabetes. Curr Diab Rep. 2020;20(6):18. doi: https://doi.org/10.1007/s11892-020-01304-0Radlinger B, Ramoser G, Kaser S. Exocrine Pancreatic Insufficiency in Type 1 and Type 2 Diabetes. Curr Diab Rep. 2020;20(6):18. doi: https://doi.org/10.1007/s11892-020-01304-0Fischer B, Hoh S, Wehler M, et al. Faecal Elastase-1: Lyophilization of Stool Samples Prevents False Low Results in Diarrhoea. Scand J Gastroenterol. 2001;36(7):771-774. doi: https://doi.org/10.1080/003655201300192058Fischer B, Hoh S, Wehler M, et al. Faecal Elastase-1: Lyophilization of Stool Samples Prevents False Low Results in Diarrhoea. Scand J Gastroenterol. 2001;36(7):771-774. doi: https://doi.org/10.1080/003655201300192058Bertolaso C, Groleau V, Schall JI, et al. Fat-Soluble Vitamins in Cystic Fibrosis and Pancreatic Insufficiency. J Pediatr Gastroenterol Nutr. 2014;58(4):443-448. doi: https://doi.org/10.1097/MPG.0000000000000272Bertolaso C, Groleau V, Schall JI, et al. Fat-Soluble Vitamins in Cystic Fibrosis and Pancreatic Insufficiency. J Pediatr Gastroenterol Nutr. 2014;58(4):443-448. doi: https://doi.org/10.1097/MPG.0000000000000272Johnson CD, Williamson N, Janssen-van Solingen G, et al. Psychometric evaluation of a patient-reported outcome measure in pancreatic exocrine insufficiency (PEI). Pancreatology. 2019;19(1):182-190. doi: https://doi.org/10.1016/j.pan.2018.11.013Johnson CD, Williamson N, Janssen-van Solingen G, et al. Psychometric evaluation of a patient-reported outcome measure in pancreatic exocrine insufficiency (PEI). Pancreatology. 2019;19(1):182-190. doi: https://doi.org/10.1016/j.pan.2018.11.013Dominguez-Muñoz JE. Management of pancreatic exocrine insufficiency. Curr Opin Gastroenterol. 2019;35(5):455-459. doi: https://doi.org/10.1097/MOG.0000000000000562Dominguez-Muñoz JE. Management of pancreatic exocrine insufficiency. Curr Opin Gastroenterol. 2019;35(5):455-459. doi: https://doi.org/10.1097/MOG.0000000000000562Zsóri G, Illés D, Terzin V, et al. Exocrine pancreatic insufficiency in type 1 and type 2 diabetes mellitus: do we need to treat it? A systematic review. Pancreatology. 2018;18(5):559-565. doi: https://doi.org/10.1016/j.pan.2018.05.006Zsóri G, Illés D, Terzin V, et al. Exocrine pancreatic insufficiency in type 1 and type 2 diabetes mellitus: do we need to treat it? A systematic review. Pancreatology. 2018;18(5):559-565. doi: https://doi.org/10.1016/j.pan.2018.05.006Mohapatra S, Majumder S, Smyrk TC, et al. Diabetes Mellitus Is Associated With an Exocrine Pancreatopathy. Pancreas. 2016;45(8):1104-1110. doi: https://doi.org/10.1097/MPA.0000000000000609Mohapatra S, Majumder S, Smyrk TC, et al. Diabetes Mellitus Is Associated With an Exocrine Pancreatopathy. Pancreas. 2016;45(8):1104-1110. doi: https://doi.org/10.1097/MPA.0000000000000609Hardt PD, Ewald N. Exocrine Pancreatic Insufficiency in Diabetes Mellitus: A Complication of Diabetic Neuropathy or a Different Type of Diabetes? Exp Diabetes Res. 2011;2011:1-7. doi: https://doi.org/10.1155/2011/761950Hardt PD, Ewald N. Exocrine Pancreatic Insufficiency in Diabetes Mellitus: A Complication of Diabetic Neuropathy or a Different Type of Diabetes? Exp Diabetes Res. 2011;2011:1-7. doi: https://doi.org/10.1155/2011/761950Søfteland E, Poulsen JL, Starup-Linde J, et al. Pancreatic exocrine insufficiency in diabetes mellitus - prevalence and characteristics. Eur J Intern Med. 2019;68:18-22. doi: https://doi.org/10.1016/j.ejim.2019.07.021Søfteland E, Poulsen JL, Starup-Linde J, et al. Pancreatic exocrine insufficiency in diabetes mellitus - prevalence and characteristics. Eur J Intern Med. 2019;68:18-22. doi: https://doi.org/10.1016/j.ejim.2019.07.021Petersmann A, Müller-Wieland D, Müller UA, et al. Definition, Classification and Diagnosis of Diabetes Mellitus. Experimental and Clinical Endocrinology & Diabetes. 2019;127(S 01):S1-7. doi: https://doi.org/10.1055/a-1018-9078Petersmann A, Müller-Wieland D, Müller UA, et al. Definition, Classification and Diagnosis of Diabetes Mellitus. Experimental and Clinical Endocrinology & Diabetes. 2019;127(S 01):S1-7. doi: https://doi.org/10.1055/a-1018-9078Pierzynowski SG, Gregory PC, Filip R, et al. Glucose homeostasis dependency on acini–islet–acinar (AIA) axis communication: a new possible pathophysiological hypothesis regarding diabetes mellitus. Nutr Diabetes. 2018;8(1):55. doi: https://doi.org/10.1038/s41387-018-0062-9Pierzynowski SG, Gregory PC, Filip R, et al. Glucose homeostasis dependency on acini–islet–acinar (AIA) axis communication: a new possible pathophysiological hypothesis regarding diabetes mellitus. Nutr Diabetes. 2018;8(1):55. doi: https://doi.org/10.1038/s41387-018-0062-9Barreto SG, Carati CJ, Toouli J, Saccone GTP. The islet-acinar axis of the pancreas: more than just insulin. American Journal of Physiology-Gastrointestinal and Liver Physiology. 2010;299(1):G10-22. doi: https://doi.org/10.1152/ajpgi.00077.2010Barreto SG, Carati CJ, Toouli J, Saccone GTP. The islet-acinar axis of the pancreas: more than just insulin. American Journal of Physiology-Gastrointestinal and Liver Physiology. 2010;299(1):G10-22. doi: https://doi.org/10.1152/ajpgi.00077.2010American Diabetes Association Professional Practice Committee. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2022. Diabetes Care. 2022;45(Supplement_1):S17-38. doi: https://doi.org/10.2337/dc22-S002American Diabetes Association Professional Practice Committee. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2022. Diabetes Care. 2022;45(Supplement_1):S17-38. doi: https://doi.org/10.2337/dc22-S002de la Iglesia-Garcia D, Vallejo-Senra N, Iglesias-Garcia J, et al. Increased Risk of Mortality Associated With Pancreatic Exocrine Insufficiency in Patients With Chronic Pancreatitis. J Clin Gastroenterol. 2018;52(8):e63-72. doi: https://doi.org/10.1097/MCG.0000000000000917de la Iglesia-Garcia D, Vallejo-Senra N, Iglesias-Garcia J, et al. Increased Risk of Mortality Associated With Pancreatic Exocrine Insufficiency in Patients With Chronic Pancreatitis. J Clin Gastroenterol. 2018;52(8):e63-72. doi: https://doi.org/10.1097/MCG.0000000000000917Perbtani Y, Forsmark CE. Update on the diagnosis and management of exocrine pancreatic insufficiency. F1000Res. 2019;8:1991. doi: https://doi.org/10.12688/f1000research.20779.1Perbtani Y, Forsmark CE. Update on the diagnosis and management of exocrine pancreatic insufficiency. F1000Res. 2019;8:1991. doi: https://doi.org/10.12688/f1000research.20779.1Ивашкин ВТ, Маев ИВ, Охлобыстин АВ, и др. Клинические рекомендации Российской гастроэнтерологической ассоциации по диагностике и лечению экзокринной недостаточности поджелудочной железы // Российский Журнал Гастроэнтерологии, Гепатологии, Колопроктологии. — 2018. — Т. 28. №228. — С. 72-100. doi: https://doi.org/10.22416/1382-4376-2018-28-2-72-100Ivashkin VT, Mayev IV, Okhlobystin AV, et al. Diagnostics and treatment of pancreatic exocrine insufficiency: clinical guidelines of the Russian gastroenterological association. Rus J Gastroenterol Hepatol Coloproctol. 2018;28(2):72-100. (In Russ.) doi: https://doi.org/10.22416/1382-4376-2018-28-2-72-100Hammer HF. Pancreatic Exocrine Insufficiency: Diagnostic Evaluation and Replacement Therapy with Pancreatic Enzymes. Digestive Diseases. 2010;28(2):339-343. doi: https://doi.org/10.1159/000319411Hammer HF. Pancreatic Exocrine Insufficiency: Diagnostic Evaluation and Replacement Therapy with Pancreatic Enzymes. Digestive Diseases. 2010;28(2):339-343. doi: https://doi.org/10.1159/000319411Российское общество хирургов, Российская Гастроэнтерологическая Ассоциация, Ассоциация хирургов-гепатологов, Эндоскопическое общество «РЭндО». Хронический панкреатит. Клинические рекомендации. 2020. Доступно по: https://cr.minzdrav.gov.ru/schema/273_4 Ссылка активна на 09.05.2023Rossiiskoe obshchestvo khirurgov, Rossiiskaia Gastroenterologicheskaia Assotsiatsiia, Assotsiatsiia khirurgov-gepatologov, Endoskopicheskoe obshchestvo «REndO». Khronicheskii pankreatit. Klinicheskie rekomendatsii 2020. (In Russ.). Доступно по: https://cr.minzdrav.gov.ru/schema/273_4 Ссылка активна на 09.05.2023Союз педиатров России, Ассоциация медицинских генетиков, Российское респираторное общество, Российское трансплантологическое общество, Ассоциация детских врачей Московской области. Кистозный фиброз (муковисцидоз). Клинические рекомендации. 2021. Доступно по: https://cr.minzdrav.gov.ru/schema/372_2 Ссылка активна на 09.05.2023Soiuz pediatrov Rossii, Assotsiatsiia meditsinskikh genetikov, Rossiiskoe respiratornoe obshchestvo, Rossiiskoe transplantologicheskoe obshchestvo, Assotsiatsiia detskikh vrachei Moskovskoi oblasti. Kistoznyi fibroz (mukovistsidoz). Klinicheskie rekomendatsii. 2021. (In Russ.). Доступно по: https://cr.minzdrav.gov.ru/schema/372_2 Ссылка активна на 09.05.2023Shimizu K, Ito T, Irisawa A, et al. Evidence-based clinical practice guidelines for chronic pancreatitis 2021. J Gastroenterol. 2022;57(10):709-724. doi: https://doi.org/10.1007/s00535-022-01911-6Shimizu K, Ito T, Irisawa A, et al. Evidence-based clinical practice guidelines for chronic pancreatitis 2021. J Gastroenterol. 2022;57(10):709-724. doi: https://doi.org/10.1007/s00535-022-01911-6Domínguez-Muñoz JE, Phillips M. Nutritional Therapy in Chronic Pancreatitis. Gastroenterol Clin North Am. 2018;47(1):95-106. doi: https://doi.org/10.1016/j.gtc.2017.09.004Domínguez-Muñoz JE, Phillips M. Nutritional Therapy in Chronic Pancreatitis. Gastroenterol Clin North Am. 2018;47(1):95-106. doi: https://doi.org/10.1016/j.gtc.2017.09.004Layer P, Kashirskaya N, Gubergrits N. Contribution of pancreatic enzyme replacement therapy to survival and quality of life in patients with pancreatic exocrine insufficiency. World J Gastroenterol. 2019;25(20):2430-2341. doi: https://doi.org/10.3748/wjg.v25.i20.2430Layer P, Kashirskaya N, Gubergrits N. Contribution of pancreatic enzyme replacement therapy to survival and quality of life in patients with pancreatic exocrine insufficiency. World J Gastroenterol. 2019;25(20):2430-2341. doi: https://doi.org/10.3748/wjg.v25.i20.2430Roberts KJ, Schrem H, Hodson J, et al. Pancreas exocrine replacement therapy is associated with increased survival following pancreatoduodenectomy for periampullary malignancy. HPB. 2017;19(10):859-867. doi: https://doi.org/10.1016/j.hpb.2017.05.009Roberts KJ, Schrem H, Hodson J, et al. Pancreas exocrine replacement therapy is associated with increased survival following pancreatoduodenectomy for periampullary malignancy. HPB. 2017;19(10):859-867. doi: https://doi.org/10.1016/j.hpb.2017.05.009Partelli S, Frulloni L, Minniti C, et al. Faecal elastase-1 is an independent predictor of survival in advanced pancreatic cancer. Digestive and Liver Disease. 2012;44(11):945-951. doi: https://doi.org/10.1016/j.dld.2012.05.017Partelli S, Frulloni L, Minniti C, et al. Faecal elastase-1 is an independent predictor of survival in advanced pancreatic cancer. Digestive and Liver Disease. 2012;44(11):945-951. doi: https://doi.org/10.1016/j.dld.2012.05.017Domínguez-Muñoz JE, Nieto-Garcia L, López-Díaz J, et al. Impact of the treatment of pancreatic exocrine insufficiency on survival of patients with unresectable pancreatic cancer: a retrospective analysis. BMC Cancer. 2018;18(1):534. doi: https://doi.org/10.1186/s12885-018-4439-xDomínguez-Muñoz JE, Nieto-Garcia L, López-Díaz J, et al. Impact of the treatment of pancreatic exocrine insufficiency on survival of patients with unresectable pancreatic cancer: a retrospective analysis. BMC Cancer. 2018;18(1):534. doi: https://doi.org/10.1186/s12885-018-4439-xGubergrits NB, Byelyayeva NV, Klochkov АY, et al. Enzyme replacement therapy, life quality and expectancy of patients with chronic pancreatitis and exocrine pancreatic insufficiency. Bulletin of the Club of Pancreatologists. 2018;41(3):10-16. doi: https://doi.org/10.33149/vkp.2018.03.02Gubergrits NB, Byelyayeva NV, Klochkov АY, et al. Enzyme replacement therapy, life quality and expectancy of patients with chronic pancreatitis and exocrine pancreatic insufficiency. Bulletin of the Club of Pancreatologists. 2018;41(3):10-16. doi: https://doi.org/10.33149/vkp.2018.03.02Jackuliak P, Payer J. Osteoporosis, Fractures, and Diabetes. Int J Endocrinol. 2014;2014:1-10. doi: https://doi.org/10.1155/2014/820615Jackuliak P, Payer J. Osteoporosis, Fractures, and Diabetes. Int J Endocrinol. 2014;2014:1-10. doi: https://doi.org/10.1155/2014/820615Ewald N, Bretzel RG, Fantus IG, et al. Pancreatin therapy in patients with insulin-treated diabetes mellitus and exocrine pancreatic insufficiency according to low fecal elastase 1 concentrations. Results of a prospective multi-centre trial. Diabetes Metab Res Rev. 2007;23(5):386-391. doi: https://doi.org/10.1002/dmrr.708Ewald N, Bretzel RG, Fantus IG, et al. Pancreatin therapy in patients with insulin-treated diabetes mellitus and exocrine pancreatic insufficiency according to low fecal elastase 1 concentrations. Results of a prospective multi-centre trial. Diabetes Metab Res Rev. 2007;23(5):386-391. doi: https://doi.org/10.1002/dmrr.708Ebert R, Creutzfeldt W. Reversal of impaired GIP and insulin secretion in patients with pancreatogenic steatorrhea following enzyme substitution. Diabetologia. 1980;19(3):198-204. doi: https://doi.org/10.1007/BF00275269Ebert R, Creutzfeldt W. Reversal of impaired GIP and insulin secretion in patients with pancreatogenic steatorrhea following enzyme substitution. Diabetologia. 1980;19(3):198-204. doi: https://doi.org/10.1007/BF00275269Knop FK, Vilsbøll T, Larsen S, et al. Increased postprandial responses of GLP-1 and GIP in patients with chronic pancreatitis and steatorrhea following pancreatic enzyme substitution. American Journal of Physiology-Endocrinology and Metabolism. 2007;292(1):E324-330. doi: https://doi.org/10.1152/ajpendo.00059.2006Knop FK, Vilsbøll T, Larsen S, et al. Increased postprandial responses of GLP-1 and GIP in patients with chronic pancreatitis and steatorrhea following pancreatic enzyme substitution. American Journal of Physiology-Endocrinology and Metabolism. 2007;292(1):E324-330. doi: https://doi.org/10.1152/ajpendo.00059.2006O’Keefe SJD, Cariem AK, Levy M. The Exacerbation of Pancreatic Endocrine Dysfunction by Potent Pancreatic Exocrine Supplements in Patients with Chronic Pancreatitis. J Clin Gastroenterol. 2001;32(4):319-323. doi: https://doi.org/10.1097/00004836-200104000-00008O’Keefe SJD, Cariem AK, Levy M. The Exacerbation of Pancreatic Endocrine Dysfunction by Potent Pancreatic Exocrine Supplements in Patients with Chronic Pancreatitis. J Clin Gastroenterol. 2001;32(4):319-323. doi: https://doi.org/10.1097/00004836-200104000-00008Mohan V, Poongothai S, Pitchumoni CS. Oral pancreatic enzyme therapy in the control of diabetes mellitus in tropical calculous pancreatitis. International Journal of Pancreatology. 1998;24(1):19-22. doi: https://doi.org/10.1007/BF02787526Mohan V, Poongothai S, Pitchumoni CS. Oral pancreatic enzyme therapy in the control of diabetes mellitus in tropical calculous pancreatitis. International Journal of Pancreatology. 1998;24(1):19-22. doi: https://doi.org/10.1007/BF02787526Whitcomb DC, Bodhani A, Beckmann K, et al. Efficacy and Safety of Pancrelipase/Pancreatin in Patients With Exocrine Pancreatic Insufficiency and a Medical History of Diabetes Mellitus. Pancreas. 2016;45(5):679-686. doi: https://doi.org/10.1097/MPA.0000000000000514Whitcomb DC, Bodhani A, Beckmann K, et al. Efficacy and Safety of Pancrelipase/Pancreatin in Patients With Exocrine Pancreatic Insufficiency and a Medical History of Diabetes Mellitus. Pancreas. 2016;45(5):679-686. doi: https://doi.org/10.1097/MPA.0000000000000514Adler G, Mundlos S, Kuhnelt P et al., New Methods for Assessment of Enzyme Activity. Digestion 1993, 54 p: 3-9.Adler G, Mundlos S, Kuhnelt P et al., New Methods for Assessment of Enzyme Activity. Digestion 1993, 54 p: 3-9.

The authors declare that there are no conflicts of interest present.